Clincosm LogoSign in Get a demo

Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use

Sponsor
Michael Sofis (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05324813
Collaborator
Dartmouth College (Other)
50
Enrollment
1
Location
2
Arms
3
Anticipated Duration (Months)
16.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The overarching goal of this online study is to compare the efficacy of six (weekly) sessions of Domain-Specific Episodic Future Thinking (DS-EFT) relative an active control condition on improving the ability to value future rewards and reducing cannabis use (grams and days of use), tobacco use, and alcohol use among.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Domain-Specific Episodic Future Thinking
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Domain-Specific Episodic Future Thinking

Behavioral: Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.
Active Comparator: Episodic Recent Thinking Control Condition

Behavioral: Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.

Outcome Measures

Primary Outcome Measures

  1. Number of cannabis use grams [1-week follow-up]

  2. Number of cannabis use days [1-week follow-up]

Secondary Outcome Measures

  1. Number of tobacco use days [1-week follow-up]

  2. Number of alcohol use days [1-week follow-up]

  3. Number of tobacco use times [1-week follow-up]

  4. Number of alcoholic drinks [1-week follow-up]

  5. Rate of delay discounting [1-week follow-up]

    5-trial adjusting delay discounting task

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • at least 18 or older

  • reside in the U.S.

  • report wanting to reduce cannabis use (4 or higher on scale of 1-10 with higher scores indicating greater desire to reduce use)

  • report using cannabis at least 10 days in the last month

  • report using cannabis at least 100 days in their lifetime

  • Data quality checks passed

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 AHP Corporate Office Sudbury Massachusetts United States 01776

Sponsors and Collaborators

  • Michael Sofis
  • Dartmouth College

Investigators

  • Principal Investigator: Michael J Sofis, PhD, AHP

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Sofis, Senior Scientist, Advocates for Human Potential
ClinicalTrials.gov Identifier:
NCT05324813
Other Study ID Numbers:
  • 7420
First Posted:
Apr 12, 2022
Last Update Posted:
Apr 12, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Marijuana Abuse
Marijuana Use

Study Results

No Results Posted as of Apr 12, 2022